ArticleImmunoHorizons2025

Exploring MHC class II I-Ab blockade as a potential treatment for Sjögren's disease in the mouse model.

Alexandria Voigt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.